[News] Revolutionary Inhaled Insulin Afrezza: A Game-Changer for Teens with Diabetes
Introduction to Inhaled Insulin The FDA has recently approved Afrezza, an inhaled insulin, for children and adolescents with diabetes. This breakthrough has been life-changing for 15-year-old Taisie Seigrist, who participated in the clinical trial for Afrezza. In this article, we will explore the benefits of inhaled insulin, its impact on Taisie’s life, and what this…